Pharma

Vertex Pharmaceuticals CEO Reshma Kewalramani Honored with the Lifetime Achievement Award 2024

November 21, 2024

Accelerating Climate Action, 11 Boston and Cambridge Institutions Collaborate to Invest in Wind and Solar Power

November 20, 2024

Lumicell’s Board of Directors Appoints Howard Hechler as Chief Executive Officer

November 13, 2024

THIS WEEK'S STORIES

Exact Sciences and Lil Jon Partner on “Get Low #2” Campaign to Encourage Colon Cancer Screening

December 2, 2024

Sudo Biosciences Announces First Participants Dosed in Phase 1 Trial of Brain-Penetrant Allosteric TYK2 Inhibitor SUDO-550

December 2, 2024

H.B. Fuller Acquires Medifill Ltd.; Signs Provisional Agreement to Acquire GEM S.r.l.

December 2, 2024

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Sudo Biosciences Announces First Participants Dosed in Phase 1 Trial of Brain-Penetrant Allosteric TYK2 Inhibitor SUDO-550

Precision BioSciences Highlights Preclinical Data and Outlines Design of First-in-Human Clinical Trial for PBGENE-HBV for Treatment of Chronic Hepatitis B

Aptar Pharma Enters into Exclusive Agreement with Cambridge Healthcare Innovations to Commercialize the Quattrii Dry Powder Inhaler Platform

Scripps Research Advances Breakthrough Regenerative Medicines to Reverse Aging-Related Diseases

Bayer and Liveo Research Launch First-of-its-Kind Blister Packaging with Improved Environmental Footprint

Most Read

H.B. Fuller Acquires Medifill Ltd.; Signs Provisional Agreement to Acquire GEM S.r.l.

Exact Sciences and Lil Jon Partner on “Get Low #2” Campaign to Encourage Colon Cancer Screening

Sudo Biosciences Announces First Participants Dosed in Phase 1 Trial of Brain-Penetrant Allosteric TYK2 Inhibitor SUDO-550

Niterra Ventures Company Invests $18M Additional Funding in Neoplas Med GmbH

EDITOR PICKS

Vertex Pharmaceuticals CEO Reshma Kewalramani Honored with the Lifetime Achievement Award 2024

Accelerating Climate Action, 11 Boston and Cambridge Institutions Collaborate to Invest in Wind and Solar Power

Lumicell’s Board of Directors Appoints Howard Hechler as Chief Executive Officer

THIS WEEK'S STORIES

Exact Sciences and Lil Jon Partner on “Get Low #2” Campaign to Encourage Colon Cancer Screening

Sudo Biosciences Announces First Participants Dosed in Phase 1 Trial of Brain-Penetrant Allosteric TYK2 Inhibitor SUDO-550

H.B. Fuller Acquires Medifill Ltd.; Signs Provisional Agreement to Acquire GEM S.r.l.

POPULAR CATEGORY

ABOUT US

FOLLOW US